ArticleFrontiers in pharmacology2021
A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.
Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review.International journal of environmental research and public health · 2023Pooled it
- Lessons Learned From COVID-19: Never Lower the Guard in Promoting Hypertension Awareness.Journal of clinical hypertension (Greenwich, Conn.) · 2025Article
- Development and Validation of Polypharmacy-Related Psychological Distress Scale (PPDS): A Preliminary Study.Behavioral sciences (Basel, Switzerland) · 2025Article
- Strategies and challenges for maintaining the continuity of essential health services during a pandemic: a scoping review.BMC health services research · 2025Article
- The psychosocial effects of the COVID-19 pandemic on Turkish older adults: is there a difference between males and females?BMC geriatrics · 2024Article
- Statins use amidst the pandemic: prescribing, dispensing, adherence, persistence, and correlation with COVID-19 statistics in nationwide real-world data from Poland.Frontiers in pharmacology · 2024Article
- A Cross-Sectional Study Identifying Medication Adherence Technologies (MATech) in Sweden Using Behavior Change Techniques.Patient preference and adherence · 2024Article
- Identifying and presenting key country-specific indicators related to medication adherence: a comprehensive study across European countries.Frontiers in pharmacology · 2024Article
- Trends in Opioid Medication Adherence During the COVID-19 Pandemic: Retrospective Cohort Study.JMIR public health and surveillance · 2023Article
- Half a Century of Fragmented Research on Deviations from Advised Therapies: Is This a Good Time to Call for Multidisciplinary Medication Adherence Research Centres of Excellence?Pharmaceutics · 2023Article
- Article
- Article
- Editorial: Recent advances in attempts to improve medication adherence-from basic research to clinical practice.Frontiers in pharmacology · 2023Article
- Perspectives of older people with uncontrolled type 2 diabetes mellitus towards medication adherence: A qualitative study.PloS one · 2023Article
- Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization.Journal of economic behavior & organization · 2022Article
- Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study.Pharmacoepidemiology and drug safety · 2022Article
- Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies.International journal of environmental research and public health · 2022Article
- Initiation of antihypertensive drugs to patients with confirmed COVID-19-A population-based cohort study in Sweden.Basic & clinical pharmacology & toxicology · 2022Article
- Telemedicine and virtual respiratory care in the era of COVID-19.ERJ open research · 2022Review
- Assessing the Capability of Government Information Intervention and Socioeconomic Factors of Information Sharing during the COVID-19 Pandemic: A Cross-Country Study Using Big Data Analytics.Behavioral sciences (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 9 institutions in 9 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important during the COVID-19 pandemic; however, diversion of resources to acute care, and physical distancing restrictions markedly affected management of NCDs. We aimed to assess the medication management practices in place for NCDs during the second wave of the COVID-19 pandemic across European countries. In December 2020, the European Network to Advance Best practices & technoLogy on medication adherencE (ENABLE) conducted a cross-sectional, web-based survey in 38 European and one non-European countries. Besides descriptive statistics of responses, nonparametric tests and generalized linear models were used to evaluate the impact on available NCD services of the number of COVID-19 cases and deaths per 100,000 inhabitants, and gross domestic product (GDP) per capita. Fifty-three collaborators from 39 countries completed the survey. In 35 (90%) countries face-to-face primary-care, and out-patient consultations were reduced during the COVID-19 pandemic. The mean ± SD number of available forms of teleconsultation services in the public healthcare system was 3 ± 1.3. Electronic prescriptions were available in 36 (92%) countries. Online ordering and home delivery of prescription medication (avoiding pharmacy visits) were available in 18 (46%) and 26 (67%) countries, respectively. In 20 (51%) countries our respondents were unaware of any national guidelines regarding maintaining medication availability for NCDs, nor advice for patients on how to ensure access to medication and adherence during the pandemic. Our results point to an urgent need for a paradigm shift in NCD-related healthcare services to assure the maintenance of chronic pharmacological treatments during COVID-19 outbreaks, as well as possible future disasters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.